Subsequently, they have functionalized their hybrid nanosystem with breast cancer-targeting bombesin, but also with folate, to improve the targeting efficacy ([177Lu]Lu-DenAuNP-folate-bombesin) [52,55]. The gene discussed is GRP; the disease is breast cancer.